By Colin Kellaher

 

Perrigo Co. on Monday said its HRA Pharma unit has filed for U.S. Food and Drug Administration approval of what would be the first over-the-counter birth-control pill in the U.S.

The Dublin-based healthcare company said it is seeking a switch for its Opill, a prescription daily birth-control pill the FDA approved in 1973, to over-the-counter status, a move Perrigo said would help remove barriers to access to contraception.

Perrigo's move comes after the Supreme Court last month eliminated the constitutional right to an abortion, overruling the 1973 Roe v. Wade decision and leaving the question of abortion's legality to the states.

 

Write to Colin Kellaher at colin.kellaher@wsj.com

 

(END) Dow Jones Newswires

July 11, 2022 06:35 ET (10:35 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.
Perrigo Company Plc Irel... (NYSE:PRGO)
Historical Stock Chart
Von Nov 2022 bis Dez 2022 Click Here for more Perrigo Company Plc Irel... Charts.
Perrigo Company Plc Irel... (NYSE:PRGO)
Historical Stock Chart
Von Dez 2021 bis Dez 2022 Click Here for more Perrigo Company Plc Irel... Charts.